The association between the infiltration activity of immune cells and CLEC3B expression in HCC further suggests that CLEC3B may be involved in the oncogenesis and progression of HCC, thus demonstrating the potential of CLEC3B as a biomarker gene. The gene discussed is CLEC3B; the disease is hepatocellular carcinoma.